Erratum: Functional ex vivo assay reveals homologous recombination deficiency in breast cancer beyond BRCA gene defects (Clin Cancer Res. (2018)24:24(6277-6287) DOI: 10.1158/1078-0432.CCR-18-0063)

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the original version of this article (1), 28 of 170 tumors were misclassified. The authors have updated the article text, Fig. 1, and Supplementary Table S3 to accurately reflect the decrease in positive tests from 148 to 125. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error. Reference 1. Meijer TG, Verkaik NS, Sieuwerts AM, van Riet J, Naipal KAT, van Deurzen CHM, et al. Functional ex vivo assay reveals homologous recombination deficiency in breast cancer beyond BRCA gene defects. Clin Cancer Res 2018;24:6277–87.

Cite

CITATION STYLE

APA

Meijer, T. G., Verkaik, N. S., Sieuwerts, A. M., Van Riet, J., Naipal, K. A. T., Van Deurzen, C. H. M., … Van Gent, D. C. (2019). Erratum: Functional ex vivo assay reveals homologous recombination deficiency in breast cancer beyond BRCA gene defects (Clin Cancer Res. (2018)24:24(6277-6287) DOI: 10.1158/1078-0432.CCR-18-0063). Clinical Cancer Research. American Association for Cancer Research Inc. https://doi.org/10.1158/1078-0432.CCR-19-0936

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free